申请人:GENENTECH, INC.
公开号:US20130123263A1
公开(公告)日:2013-05-16
Benzopyran and benzoxepin compounds of Formulas I and II, and including stereoisomers, geometric isomers, tautomer solvates, metabolites and pharmaceutically acceptable salts thereof, are useful for inhibiting lipid kinases including p110 alpha and other isoforms of PI3K, and for treating disorders such as cancer mediated by lipid kinases. Methods of using compounds of Formulas I and II for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.
公式I和II的苯并吡喃和苯并氧杂环化合物,包括立体异构体、几何异构体、互变异构体、代谢产物和其药学上可接受的盐,可用于抑制脂质激酶,包括p110 alpha和其他PI3K的同工酶,并用于治疗由脂质激酶介导的癌症等疾病。揭示了使用公式I和II化合物的方法,用于哺乳动物细胞中的体外、原位和体内诊断、预防或治疗此类疾病或相关病理条件。